ArticleCureus2026
Cannabis Use Disorder Is Associated With Increased Risk of Acute Myocardial Infarction in Adults With Metabolic Dysfunction-Associated Steatohepatitis (MASH) Cirrhosis: A Population-Based Analysis.
Article in Cureus, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
introductionCannabis use disorder (CUD) is encountered among hospitalized adults with metabolic dysfunction-associated steatohepatitis (MASH) cirrhosis. Both conditions are independently associated with adverse cardiometabolic profiles, raising concern for potential cardiovascular complications when they coexist. This study evaluated the association between CUD and acute myocardial infarction (MI) among hospitalized adults with MASH cirrhosis.
methodsWe performed a retrospective cross-sectional analysis of the National Inpatient Sample from 2016 to 2020, including adults aged ≥18 years hospitalized with MASH cirrhosis. CUD was identified using the International Classification of Diseases, Tenth Revision, Clinical Modification (ICD-10-CM) codes. Multivariable logistic and Poisson regression models were used to examine associations between CUD and acute MI, in-hospital mortality, major adverse cardiovascular events, hepatic decompensation, length of stay, and hospitalization costs, adjusting for demographics, comorbidities, and hospital characteristics.
resultsAmong 57,754 hospitalizations for MASH cirrhosis, 539 involved patients with CUD. CUD was associated with a significantly higher likelihood of acute MI (adjusted odds ratio 2.18; 95% CI 1.30-3.63). No significant associations were observed between CUD and in-hospital mortality or overall major adverse cardiovascular events. CUD was associated with lower odds of hepatic decompensation. Hospitalizations involving CUD were associated with lower adjusted costs, while length of stay did not differ significantly between groups.
conclusionAmong hospitalized adults with MASH cirrhosis, CUD was associated with a higher risk of acute MI but not with increased in-hospital mortality or overall major adverse cardiovascular events. These findings underscore the importance of cardiovascular risk assessment and CUD identification in this population. As this was an observational cross-sectional study, the findings represent associations and do not establish causality.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.